Plus: polypharmacy in the elderly; sotagliflozin and CKD
Tuesday, Nov. 3, 2020 : Issue #1077 |
|
Letter from the Editor
Years ago I delivered a CE for pharmacists on the relation of diabetes and obstructive sleep apnea. I went back and looked at the data, and there was a strong correlation between OSA, hypertension and diabetes.
Typically getting a patient on a CPAP device is the only choice available, but now new research on a well known diabetes drug shows reduction in sleep apnea in these patients, while also reducing A1c and cardiovascular risk.
Check out our feature article from Tarshay Boyd, PharmD. Candidate, LECOM School of Pharmacy, to learn what this medication is.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief |
|
| |
|
|
|
TOP STORIES - Diabetes News and Research |
|
| |
|
|
|
| | | | About LaterPay: You will notice that some of our articles are now marked with a small credit card icon. This means you will be asked to pay a small fee to access the full article text (the cost is $0.39 per article, and you will be charged only after you have reached $5.00 in article views). The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control. |
| Your Friends in Diabetes Care
Steve and Dave
Diabetes In Control
810 Bear Tavern Road Suite 102
Ewing, NJ, 08628
USA
www.diabetesincontrol.com |
|
|
|
|
| | |
|
|
|
|
